IP Library Granted Patent US 10,934,596
Granted Patent B2
US 10,934,596 · App. 15/949,516 · Granted Mar 2, 2021

Automated microbial detection and quantification

Inventors: Jack Gilbert (Naperville, IL); Charles Catlett (Lemont, IL); Peter Beckman (Lemont, IL)
Assignee: UChicago Argonne, LLC
C12Q1/6888B01L3/502715C12Q1/689C12Q1/6825C12Q1/6844C12Q1/701G01N1/2273G01N15/1459G01N15/1484G01N21/6428G01N27/021B01L2200/0647B01L2200/0652B01L2200/16B01L2300/0636B01L2300/0645B01L2300/0672B01L2400/0415G01N2001/2223G01N2015/0046G01N2015/0065G01N2021/6439
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,934,596
App. No.
15/949,516
Granted
Mar 2, 2021
Kind
B2
Abstract

A method for automated microbial detection includes collecting air particles into a solid-state sampler, the air particles including microbes, charging the air particles using a plasma field generated by propulsion electrodes, focusing the charged air particles toward a sample well of a microfluidic testing cartridge, tagging the charged air particles with a fluorescence marker, and detecting a quantity of the microbes using a fluorescence detector.

Claims (33)

1. A method for automated microbial detection, comprising:

collecting air particles into a solid-state sampler, the air particles including microbes;

charging the air particles using a plasma field generated by propulsion electrodes;

focusing the charged air particles toward a sample well of a microfluidic testing cartridge;

tagging the charged air particles with a fluorescence marker;

detecting a quantity of the microbes using a fluorescence detector.

2. The method of claim 1 , further comprising:

transmitting a signal of the fluorescence detector to a remote storage and analysis device;

discarding the microfluidic testing cartridge; and

loading an unused microfluidic testing cartridge.

3. The method of claim 1 , wherein the microbes comprise at least one of bacteria, archaea, fungi, viruses, or a combination thereof.

4. The method of claim 1 , wherein the solid-state sampler is an electro-kinetic ion focuser.

5. The method of claim 1 , wherein the step of tagging the charged air particles comprises:

puncturing a liquid cartridge comprising cell-lysis chemicals with an impaling structure embedded in the microfluidic testing cartridge releasing the cell-lysis chemicals;

flowing the released cell-lysis chemicals into the sample well;

mixing the flowed cell-lysis chemicals with the charged air particles, forming a blend;

flowing the blend into a mixing chamber of the microfluidic testing cartridge to re-suspend the charged particles in the cell-lysis chemicals; and

distributing the blend into at least one assay chamber of the microfluidic testing cartridge.

6. The method of claim 5 , wherein the step of distributing the blend into at least one assay chamber comprises:

activating pre-existing DNA polymerase, genotype-specific DNA oligomer primers, and fluorescent marker in each assay chamber;

heating each assay chamber to enable isothermal DNA amplification; and

binding the amplified DNA with the fluorescent marker.

7. The method of claim 6 , wherein the DNA polymerase is a Phi29 rolling circle DNA polymerase.

8. The method of claim 5 , wherein the cell-lysis chemicals comprise a lysis buffer, cellular lysate, and at least one detergent.

9. A method of tagging charged particles comprising:

puncturing a liquid cartridge comprising cell-lysis chemicals with an impaling structure to release the cell-lysis chemicals;

mixing the released cell-lysis chemicals with charged air particles including microbes to form a blend;

contacting, in an assay chamber, the blend with a mixture preexisting in the assay chamber, the mixture comprising DNA polymerase, genotype-specific DNA oligomer primers, and fluorescent marker to form a system;

heating the system to enable isothermal DNA amplification; and

binding the amplified DNA with the fluorescent marker,

wherein the charged particles are suspended in the cell-lysis chemicals.

10. The method of claim 9 , wherein the DNA polymerase is a Phi29 rolling circle DNA polymerase.

11. The method of claim 9 , wherein the cell-lysis chemicals comprise a lysis buffer, cellular lysate, and at least one detergent.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 15, 2021
From: UCHICAGO ARGONNE, LLC
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 056551/0272 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2020
From: GILBERT, JACK; BECKMAN, PETER; CATLETT, CHARLES
To: UCHICAGO ARGONNE, LLC
Reel/Frame 054529/0540 →
Continuity (2)
Provisional Application 62488672 · Apr 21, 2017
Related Publication 20180305772A1 · Oct 25, 2018
Cited By (1)
US 12,270,747